Exvastat

📍 Cambridge, United Kingdom🗓 Founded 2016👥 7 employees💰 Last funded Jan 2017
Pharmaceutical Manufacturing🌐 exvastat.com
Website LinkedIn
Exvastat is an innovative, preclinical-stage pharmaceutical company founded in 2016. The company is developing a treatment for acute respiratory distress syndrome (ARDS) based on a repurposed drug which is marketed worldwide for other indications. The new treatment has the potential to significantly reduce the high mortality and incapacitating morbidities caused by ARDS, as well as the costs of caring for these critically ill patients to health service providers.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2016
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United Kingdom
1
Frequently asked questions
Who invested in Exvastat?
Exvastat has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Exvastat last raise funding?
The most recent investment in Exvastat recorded on gritt.io was in January 2017.
When was Exvastat founded?
Exvastat was founded in 2016.
What industry is Exvastat in?
Exvastat operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is Exvastat based?
Exvastat is headquartered in Cambridge, United Kingdom.